Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
GLUCOSAMINE SULPHATE SODIUM CHLORIDE
Clonmel Healthcare Ltd
GLUCOSAMINE SULPHATE SODIUM CHLORIDE
1500 Base Milligrams
Powder for Oral Solution
Product subject to prescription which may be renewed (B)
Withdrawn
2013-11-06
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Arthrimel Once Daily 1500mg Powder for Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 1884 mg of glucosamine sulfate and sodium chloride equivalent to 1500 mg of glucosamine sulfate and 384 mg of sodium chloride or to 1178 mg glucosamine. Excipients: Each sachet contains 2.5 mg aspartame, 2,023.5 mg sorbitol and 6.57 mmol (or 151 mg) sodium. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Powder for oral solution. Off-white to yellowish homogeneous powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Relief of symptoms in mild to moderate osteoarthritis of the knee. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION One sachet, dissolved in a glass of water, once daily for relief of symptoms. Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (especially pain relief) may not be experienced until after several weeks of treatment and in some cases even longer. If no relief of symptoms is experienced after 2-3 months, continued treatment with glucosamine should be re-evaluated. Sachets can be taken with or without food. Additional information on special populations. _Children and Adolescents_ Arthrimel is not recommended for use in children and adolescents below the age of 18 years (see section 4.4). _Elderly_ No specific studies have been performed in the elderly, but according to clinical experience dosage adjustment is not required when treating otherwise healthy, elderly patients. _Impaired renal and/or liver function_ In patients with impaired renal and/or liver function no dose recommendations can be given, since no studies have been performed. IRISH MEDICINES BOARD _____________________________________________________________ Citiți documentul complet